Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 3A2 is an enzyme found primarily in rodent liver microsomes. It belongs to the cytochrome P450 superfamily and mediates the oxidative metabolism of many drugs, steroids, and toxins. The core structure contains a heme-iron center, which, upon substrate binding, facilitates oxygen transfer and the chemical transformation of substrates. This enzyme is critical for drug clearance, and its activity is modulated by various inhibitors and inducers, leading to clinically relevant pharmacokinetic interactions. In humans, the closely related CYP3A4 isozyme fulfills a similar function and is central to many adverse drug events and therapeutic outcomes
Drug substrate oxidation (hydroxylation, demethylation, etc.) Enzyme inhibition (e.g., competitive, non-competitive inhibition by ketoconazole, erythromycin) Enzyme induction (e.g., by rifampicin, carbamazepine)
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 3A2 (CYP3A2).